PERIOGARD MOUTHWASH

Country: Kanada

Bahasa: Inggeris

Sumber: Health Canada

Bahan aktif:

CHLORHEXIDINE GLUCONATE

Boleh didapati daripada:

COLGATE-PALMOLIVE CANADA INC

Kod ATC:

A01AB03

INN (Nama Antarabangsa):

CHLORHEXIDINE

Dos:

0.12%

Borang farmaseutikal:

MOUTHWASH

Komposisi:

CHLORHEXIDINE GLUCONATE 0.12%

Laluan pentadbiran:

BUCCAL

Unit dalam pakej:

470ML

Jenis preskripsi:

Prescription

Kawasan terapeutik:

MISCELLANEOUS ANTI-INFECTIVES

Ringkasan produk:

Active ingredient group (AIG) number: 0107629007; AHFS:

Status kebenaran:

CANCELLED POST MARKET

Tarikh kebenaran:

2018-10-10

Ciri produk

Page 1 of 19
PRODUCT MONOGRAPH
PERIOGARD
Chlorhexidine Gluconate 0.12% Oral Rinse, USP
Liquid, 0.12% Chlorhexidine Gluconate
Antigingivital Oral Rinse
Colgate-Palmolive Canada Inc. Date of Revision:
Two Morneau Shepell Centre
December 3, 2019
5
th
Floor, 895 Don Mills Road
Toronto, Ontario M3C 1W3
Submission Control No: 232067
Page 2 of 19
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
............................................................................
3
SUMMARY PRODUCT INFORMATION
.............................................................................................
3
INDICATIONS AND CLINICAL USE
...................................................................................................
3
CONTRAINDICATIONS
.......................................................................................................................
4
WARNINGS AND PRECAUTIONS
.....................................................................................................
4
ADVERSE REACTIONS
.......................................................................................................................
5
DOSAGE AND ADMINISTRATION
.....................................................................................................
6
OVERDOSAGE
.....................................................................................................................................
7
ACTION AND CLINICAL PHARMACOLOGY
.....................................................................................
8
STORAGE AND STABILITY
................................................................................................................
9
SPECIAL HANDLING INSTRUCTIONS
............................................................................................
10
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................................. 10
PART II: SCIENTIFIC INFORMATION
..................................................................................................
11
P